Corrs Chambers Westgarth

An expert will not be asked to determine a potential cross-claim by Downer EDI Rail in a dispute with John Holland over a rollingstock manufacturing facility being constructed in Torbanlea.

The Full Federal Court has upheld a decision revoking Otsuka Pharmaceuticals’ patent extension for an injectable version of antipsychotic drug Abilify, finding the patent expired last year.

Facebook owner Meta has argued the Australian Competition and Consumer Commission has “misallocated responsibility” in its three-year-old case over scam cryptocurrency ads on the social media platform.

Biotech Regeneron and drug company Bayer have resolved their appeal of a ruling that allowed generic pharmaceutical manufacturer Sandoz to launch a version of top selling macular degeneration drug Eylea. 

Real estate asset manager Dexus has won access to advice given by the lawyers of two shareholders of airport operator APAC over an alleged breach of a shareholder deed. 

Chinese car brand LDV is fighting the consumer regulator's case alleging it misled customers about its vehicles, telling a court that ads showing the vehicles as durable in off-road terrains were not misleading. 

Dexus has claimed legal professional privilege prevents fellow owners of airport operator APAC from accessing tens of thousands of documents as they prepare for trial over an alleged breach of a shareholder deed.

The Full Federal Court will hear developer Robert Filippini’s appeal of freezing orders won by Keystone Asset Management's liquidators, as ASIC's investigation of Keystone's failed Shield fund ramps up.

The Takeovers Panel has found Cosette cannot close a Mayne Pharma drug manufacturing plant in Adelaide, another win for Mayne in its push to block the US drug maker from walking away from their $672 million merger.

The Foreign Investment Review Board has extended the deadline for ruling on Cosette's proposed $672 million takeover of Mayne Pharma.